Ainos (NASDAQ:AIMD) Releases Earnings Results

Ainos (NASDAQ:AIMD) announced its quarterly earnings data on Friday. The company reported ($0.26) earnings per share (EPS) for the quarter, Zacks reports.

Ainos Stock Up 2.9 %

Shares of Ainos stock traded up $0.01 during trading on Friday, hitting $0.49. 888,270 shares of the stock traded hands, compared to its average volume of 865,918. The company has a fifty day moving average price of $0.62 and a two-hundred day moving average price of $0.55. Ainos has a twelve month low of $0.40 and a twelve month high of $3.10. The company has a quick ratio of 1.33, a current ratio of 1.37 and a debt-to-equity ratio of 0.50.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.